Literature DB >> 2496995

Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.

E J Kuijper1, M F Peeters, B S Schoenmakers, H C Zanen.   

Abstract

The MICs of 21 antimicrobial agents were determined for 60 strains of Aeromonas spp. isolated from human feces. All isolates tested were susceptible to aztreonam, tetracycline, imipenem, moxalactam, pipemidic acid, gentamicin, trimethoprim-sulfamethoxazole, pefloxacin and ciprofloxacin. Resistance to erythromycin and streptomycin was observed in all 60 strains. Aeromonas caviae was less susceptible to cefamandole, cefotaxime, norfloxacin, chloramphenicol, tetracycline, sulfamethoxazole and trimethoprim than was either Aeromonas hydrophila or Aeromonas sobria. It was concluded that cotrimoxazole or one of the newer quinolones can be considered for treatment of aeromonas-associated diarrhea.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496995     DOI: 10.1007/bf01965270

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Phenotypic characterization and DNA relatedness in human fecal isolates of Aeromonas spp.

Authors:  E J Kuijper; A G Steigerwalt; B S Schoenmakers; M F Peeters; H C Zanen; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

2.  In-vitro susceptibility of Aeromonas app. to antimicrobial agents.

Authors:  C J Richardson; J O Robinson; L B Wagener; V Burke
Journal:  J Antimicrob Chemother       Date:  1982-04       Impact factor: 5.790

3.  In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  Antimicrobial susceptibility of Aeromonas hydrophila.

Authors:  T L Overman
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Biochemical characteristics, enterotoxigenicity and susceptibility to antimicrobial agents of clinical isolates of Aeromonas species encountered in the western region of Saudi Arabia.

Authors:  P J Gosling
Journal:  J Med Microbiol       Date:  1986-08       Impact factor: 2.472

6.  Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

Authors:  J F Reinhardt; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea.

Authors:  V H San Joaquin; R K Scribner; D A Pickett; D F Welch
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

8.  Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila.

Authors:  K Shannon; A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

9.  In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.

Authors:  M A Miller; M Finan; M Yousuf
Journal:  J Antimicrob Chemother       Date:  1983-04       Impact factor: 5.790

10.  In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

Authors:  M R Motyl; G McKinley; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more
  3 in total

Review 1.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

2.  In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents.

Authors:  A Burgos; G Quindós; R Martínez; P Rojo; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

3.  Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors:  T L Overman; J M Janda
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.